You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Kleiner Device Labs

From EverybodyWiki Bios & Wiki






Script error: No such module "Draft topics". Script error: No such module "AfC topic".


Kleiner Device Labs
AbbreviationKDL
NicknameKleiner Labs
PredecessorSpinal Surgical Strategies, LLC
FounderJeffrey B. Kleiner, MD
Founded atIncline Village, Nevada
TypeC Corporation
Legal statusCompany
PurposeImproving instruments & outcomes for spine surgery while lowering costs for patients, surgeons, hospitals, and payers.[1]
HeadquartersIncline Village, Nevada
Location
OriginsSurgeon research on bone graft dispersion/volume and clinical outcomes[2]
ProductsSpinal fusion Implants Bone grafting Instrumentation [3]
FieldsMedtech[4]
Key people
Jeffrey B. Kleiner, MD (CEO), Alan Burkholder (CTO)
Award(s)2022 Medical Design Excellence Awards (Implant and Tissue-Replacement Products category)[5][6]
Websitekleinerlabs.com
Formerly called
Spinal Surgical Strategies, LLC

Kleiner Device Labs is a medical device company focused on the development of Implants and Bone grafting Instrumentation for spine surgery.[7] The company was founded in 2013 by Stanford graduate and spine surgeon Jeffrey B. Kleiner, MD (after 25+ years of active surgical practice).[8] The organization maintains a portfolio of 23 patents for its technologies.[citation needed][9]

FDA 510(k) cleared products[edit]

  • KG2 System - FDA cleared on September 14, 2021.[10] First use in patient on July 19, 2022.[11][12][13]
  • KG1 Bi-Portal Bone Graft Delivery Device - FDA cleared on December 11, 2014.[14] Commercially available January 11, 2018.[15][16]

References[edit]

  1. Labs, Kleiner Device. "Kleiner Device Labs". Kleiner Device Labs.
  2. Kleiner, Jeffrey B.; Kleiner, Hannah M.; Jr, E. John Grimberg; Throlson, Stefanie J. (May 13, 2016). "Evaluation of a novel tool for bone graft delivery in minimally invasive transforaminal lumbar interbody fusion". Medical Devices: Evidence and Research. 9: 105–114. doi:10.2147/MDER.S100098. PMC 4876849. PMID 27274320 – via www.dovepress.com.
  3. "Graft Delivery Device Market Major Developments and Competition Landscape by 2030".
  4. Kumar, Sweeny (May 17, 2021). "Kleiner Device Labs on Equifund CFP". KingsCrowd.
  5. "2022 Medical Design Excellence Awards Winners". mddionline.com. April 6, 2022.
  6. "Kleiner Device Labs' KG2 Surge flow-thru interbody system named finalist for MD+DI Medical Design Excellence Award | Spinal Surgery News". www.spinalsurgerynews.com.
  7. Condon, Alan. "23 spine device companies to watch in 2022". www.beckersspine.com. Retrieved 2022-08-26.
  8. Tudoran, Paula (2022-01-27). "This Medical Startup Could Disrupt The $14 Billion Spinal Fusion Market: Last Call To Invest". Benzinga. Retrieved 2022-08-26.
  9. "Becker's named 23 spine device companies to watch in 2022: Where are they now?".
  10. Health, Center for Devices and Radiological (2021-10-18). "September 2021 510(K) Clearances". FDA.
  11. "Leading Spine Surgeon at The Brooklyn Hospital Center First to Perform New Spinal Fusion Procedure". The Brooklyn Hospital Center. 2022-08-01. Retrieved 2022-08-26.
  12. Behm, Carly. "Dr. Anders Cohen debuts Kleiner Device Labs interbody system". www.beckersspine.com. Retrieved 2022-08-26.
  13. Vetalice, Julie A. (August 1, 2022). "First Case with Kleiner Device Labs' KG2 Surge Flow-Thru Interbody". Orthoworld. Retrieved August 26, 2022.
  14. "510(k) Premarket Notification". www.accessdata.fda.gov. Retrieved 2022-08-26.
  15. "Kleiner introduces new spinal bone graft delivery tool". NS Medical Devices. 2018-01-11. Retrieved 2022-08-26.
  16. "Research". www.healthpointcapital.com. Retrieved 2022-08-26.



This article "Kleiner Device Labs" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Kleiner Device Labs. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.